Ramillete, Meralyn T.
HRN: 22-77-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2023
CEFUROXIME 500MG (TAB)
03/27/2023
04/03/2023
PO
500mg
BID X 7 Days
S/p NSVD With Repair Of First Degree Perineal Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes